Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02901574 · ClinicalTrials.gov registry record · NA
Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02901574: Completed NA study, sponsored by Johns Hopkins University.
NCT02901574 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02901574, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
People with post-stroke aphasia are left with some degree of chronic deficit for which current rehabilitative treatments are variably effective. This study investigates the behavioral and neural effects of multiple consecutive cerebellar tDCS sessions coupled with computerized naming therapy in stroke survivors with aphasia.
Interventions
- DEVICE Sham
- DEVICE Anodal or Cathodal tDCS
- BEHAVIORAL Computerized naming therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-09-19 |
| Est. Completion | 2022-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02901574
The ClinicalTrials.gov registry entry for NCT02901574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham is the first listed.
NCT02901574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02901574 about?
NCT02901574 is a clinical study titled "Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment". People with post-stroke aphasia are left with some degree of chronic deficit for which current rehabilitative treatments are variably effective. This study investigates the behavioral and neural effects of multiple consecutive cerebellar tDCS sessions coupled with computerized naming therapy in stro...
What is the current status of trial NCT02901574?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-09-19. Estimated completion is 2022-05-20.
What interventions are being tested in trial NCT02901574?
The interventions under investigation include: Sham (DEVICE), Anodal or Cathodal tDCS (DEVICE), Computerized naming therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02901574?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.